Enabling the biomedical community to bring lifesaving therapies faster to the market

K.T. Rama Rao, Minister for Municipal Administration & Urban Development, Industries & Commerce, and Information Technology, Government of Telangana, inaugurated the state-of-the-art facility of GV Safety Assessment Platform (GVSAP), at Genome Valley, Hyderabad.

 
GVSAP is the Preclinical services vertical of GV Research Platform (GVRP) involved in commercial breeding of Specific Pathogen Free (SPF) research models and preclinical testing.

 

Spread across 28,000 sq.ft., the Class 100,000 research facility is equipped with the latest in clean-room technology and robust building management system.
 
GVSAP is the authorized breeding and distribution partners in India for Envigo RMS LLC, a US-based global leader in research models and related services. This partnership will support biomedical companies in India to locally source premier high quality Specific Pathogen Free (SPF) Envigo branded research models in accelerating their research programmes. Additionally, GVSAP will also extend preclinical R&D services like toxicology, pharmacology, and bioanalytical focused on both in-vitro and in-vivo research.
 
The current ecosystem relies heavily on the import of SPF models from international suppliers to meet their preclinical research demands. Considering increasing implications of research models in oncology, chronic infectious diseases, and for vaccine batch release and potency testing, the import of these models from international suppliers directly adds to the R&D cost.